Indication
Severe chronic neutropenia
Severe chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months. Read more about Severe chronic neutropenia
8 drugs 5 manufacturers
Drugs that treat it
Common Severe chronic neutropenia therapies.
NEUPOGEN (filgrastim)
NIVESTYM (filgrastim-aafi)
NIVESTYM (filgrastim-aafi)
RELEUKO (filgrastim-ayow)
RELEUKO (filgrastim-ayow)
NYPOZI (filgrastim-txid)
FILKRI (filgrastim-laha)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSevere chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months.
It affects both pediatric and adult populations and encompasses distinct subtypes, including congenital, cyclic, and idiopathic forms.
Pathophysiologically, the condition often stems from genetic mutations—such as in the ELANE gene—or autoimmune processes that cause myeloid maturation arrest in the bone marrow or accelerated peripheral neutrophil destruction.
Clinically, this profound neutrophil deficiency impairs host defense against pathogens, predisposing individuals to recurrent fevers, mucosal ulcerations, cellulitis, and life-threatening systemic bacterial infections.
- nih.gov
Severe chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months Clinically, this profound neutrophil deficiency impairs host defense against pathogens, predisposing individuals to recurrent fevers, mucosal ulcerations, cellulitis, and life-threatening systemic bacterial infections
- merckmanuals.com
Severe chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months Clinically, this profound neutrophil deficiency impairs host defense against pathogens, predisposing individuals to recurrent fevers, mucosal ulcerations, cellulitis, and life-threatening systemic bacterial infections
- nih.gov
It affects both pediatric and adult populations and encompasses distinct subtypes, including congenital, cyclic, and idiopathic forms
- youtube.com
It affects both pediatric and adult populations and encompasses distinct subtypes, including congenital, cyclic, and idiopathic forms
- nih.gov
Pathophysiologically, the condition often stems from genetic mutations—such as in the ELANE gene—or autoimmune processes that cause myeloid maturation arrest in the bone marrow or accelerated peripheral neutrophil destruction
- primaryimmune.org
Pathophysiologically, the condition often stems from genetic mutations—such as in the ELANE gene—or autoimmune processes that cause myeloid maturation arrest in the bone marrow or accelerated peripheral neutrophil destruction
- rarediseases.org
Clinically, this profound neutrophil deficiency impairs host defense against pathogens, predisposing individuals to recurrent fevers, mucosal ulcerations, cellulitis, and life-threatening systemic bacterial infections
Personalize your experience
Follow Severe chronic neutropenia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.